AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...
Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC: Our Bureau, Mumbai Wednesday, Dece ...
As of Tuesday, December 16, Relay Therapeutics, Inc.’s RLAY share price has surged by 6.25%, which has investors questioning ...
Stay updated on key stocks like Ola Electric, Reliance, NBCC, and more as major deals and announcements drive today's ...
Stocks to Watch today, December 17, 2025: Indian equity markets are anticipated to open flat on Wednesday, December 17, 2025, ...
Shares of firms like IndiGo, Ola Electric, Vedanta, HDFC Bank, IndusInd Bank, NBCC, and others will be in focus on ...
Key stocks to watch include Reliance, Ola Electric, IOB, Akzo Nobel, and Glenmark amid significant corporate developments.
New evidence suggests that the risk for fracture increases within months of low-dose prednisone, challenging the idea of a ...
Stocks like Akzo Nobel India, Kaynes Technology India, Ahluwalia Contracts, Saregama India, HCL Technologies, NBCC,Glenmark ...
US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...
HealthDay on MSN
American Society of Hematology, Dec. 6 to 9
The annual meeting of the American Society of Hematology was held from Dec. 6 to 9 in Orlando, Florida, and attracted ...
Stocks including Nephrocare, Reliance, Park Medi, Akzo Nobel, Indian Overseas Bank, Vedanta, NBCC, Ola Electric, RVNL, Lupin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback